PND1 Ivacaftor for Patients with Cystic Fibrosis: Clinical Efficacy and Cost-Effectiveness

Simple item page
dc.contributor.authorKostyuk, A.
dc.contributor.authorNurgozhin, T.
dc.contributor.authorAkanov, A.
dc.creatorA., Kostyuk
dc.date.accessioned2017-12-15T06:22:23Z
dc.date.available2017-12-15T06:22:23Z
dc.date.issued2014-11-01
dc.identifierDOI:10.1016/j.jval.2014.08.538
dc.identifier.citationA. Kostyuk, T. Nurgozhin, A. Akanov, PND1 - Ivacaftor for Patients with Cystic Fibrosis: Clinical Efficacy and Cost-Effectiveness, In Value in Health, Volume 17, Issue 7, 2014, Pages A808-A809en_US
dc.identifier.issn10983015
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S1098301514024681
dc.identifier.urihttp://nur.nu.edu.kz/handle/123456789/2943
dc.language.isoenen_US
dc.publisherValue in Healthen_US
dc.relation.ispartofValue in Health
dc.rights.licenseCopyright © 2014 Published by Elsevier Inc.
dc.titlePND1 Ivacaftor for Patients with Cystic Fibrosis: Clinical Efficacy and Cost-Effectivenessen_US
dc.typeArticleen_US
elsevier.aggregationtypeJournal
elsevier.coverdate2014-11-01
elsevier.coverdisplaydateNovember 2014
elsevier.endingpageA809
elsevier.identifier.doi10.1016/j.jval.2014.08.538
elsevier.identifier.eid1-s2.0-S1098301514024681
elsevier.identifier.piiS1098-3015(14)02468-1
elsevier.issue.identifier7
elsevier.openaccess1
elsevier.openaccessarticletrue
elsevier.openaccessuserlicensehttp://www.elsevier.com/open-access/userlicense/1.0/
elsevier.openarchivearticletrue
elsevier.startingpageA808
elsevier.volume17
workflow.import.sourcescience

Files

Collections

Articles